The goal of the Lupus Foundation of America's Collective Data Analysis Initiative (LFA CDAI) is to improve clinical trial design so new treatments can get to people who need them faster. The LFA CDAI ...
Following completion of the Week 14 visit, rosnilimab-treated patients who achieved CDAI low disease activity (LDA) of ≤ 10, continued their assigned treatment through Week 28 in a blinded ...